The Ozempic Face Phenomenon: Understanding Why Patients Are Abandoning GLP-1 Weight-Loss Drugs
The Emergence of ‘Ozempic Face’ and Treatment Dropout Patients across the globe are increasingly discontinuing the use of popular GLP-1 receptor agonists, such as Ozempic and Wegovy, as reports of rapid physical transformation—specifically facial volume loss—drive concerns about long-term aesthetic and metabolic side effects. Clinical data suggests that while these medications are highly effective for…